Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alireza Atri, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Petersen RC, Aisen PS, Andrews JS, Atri A, Matthews BR, Rentz DM, Siemers ER, Weber CJ, Carrillo MC. Expectations and clinical meaningfulness of randomized controlled trials. Alzheimers Dement. 2023 Feb 07. PMID: 36748826.
    Citations:    Fields:    
  2. Mohebpour I, Malek-Ahmadi M, Virden T, Breitmeyer A, Sabbagh MN, Auman B, Belden CM, Choudhury P, Arch A, Davis K, Cline C, Moorley N, Atri A, Serrano G, Beach TG. Neuropathologic validation of the Alzheimer's Questionnaire. Aging Clin Exp Res. 2022 Nov; 34(11):2905-2909. PMID: 36031683.
    Citations:    Fields:    Translation:Humans
  3. Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D, Montine TJ, Berry GJ, Reiman EM, Röltgen K, Boyd SD, Pinsky BA, Zehnder JL, Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J Neuropathol Exp Neurol. 2022 08 16; 81(9):666-695. PMID: 35818336; PMCID: PMC9278252.
    Citations:    Fields:    
  4. Tremblay C, Serrano GE, Intorcia AJ, Mariner MR, Sue LI, Arce RA, Atri A, Adler CH, Belden CM, Shill HA, Driver-Dunckley E, Mehta SH, Beach TG. Olfactory Bulb Amyloid-ß Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment. J Neuropathol Exp Neurol. 2022 07 19; 81(8):643-649. PMID: 35751438; PMCID: PMC9297096.
    Citations:    Fields:    Translation:Humans
  5. Nirogi R, Ieni J, Goyal VK, Ravula J, Jetta S, Shinde A, Jayarajan P, Benade V, Palacharla VRC, Dogiparti DK, Jasti V, Atri A, Cummings J. Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept study. Alzheimers Dement (N Y). 2022; 8(1):e12307. PMID: 35662833; PMCID: PMC9157584.
    Citations: 1     
  6. Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease. Alzheimers Res Ther. 2022 04 19; 14(1):54. PMID: 35440022; PMCID: PMC9017027.
    Citations:    Fields:    Translation:Humans
  7. Tremblay C, Serrano GE, Intorcia AJ, Curry J, Sue LI, Nelson CM, Walker JE, Glass MJ, Arce RA, Fleisher AS, Pontecorvo MJ, Atri A, Montine TJ, Chen K, Beach TG. Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy. J Neuropathol Exp Neurol. 2022 02 24; 81(3):158-171. PMID: 35191506.
    Citations: 1     Fields:    Translation:HumansCells
  8. Lea R, Benge JF, Adler CH, Beach TG, Belden CM, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease. J Clin Exp Neuropsychol. 2021 11; 43(9):918-925. PMID: 35138228; PMCID: PMC8881345.
    Citations:    Fields:    Translation:Humans
  9. Cummings JL, Ismail Z, Dickerson BC, Ballard C, Grossberg G, McEvoy B, Foff E, Atri A. Development and assessment of a brief screening tool for psychosis in dementia. Alzheimers Dement (Amst). 2021; 13(1):e12254. PMID: 34934801; PMCID: PMC8650749.
    Citations:    
  10. Cummings JL, Atri A, Ismail Z, Dickerson BC, Ballard C, Grossberg GT, McEvoy B, Foff E. Development and assessment of a brief screening tool for psychosis in dementia. Alzheimers Dement. 2021 Dec; 17 Suppl 8:e057766. PMID: 34971295.
    Citations:    Fields:    
  11. Goldfarb D, Allen AM, Nisson LE, Petitti DB, Saner D, Langford C, Burke WJ, Reiman EM, Atri A, Tariot PN. Design and Development of a Community-Based, Interdisciplinary, Collaborative Dementia Care Program. Am J Geriatr Psychiatry. 2022 06; 30(6):651-660. PMID: 34893448.
    Citations:    Fields:    Translation:Humans
  12. Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano G, Shprecher DR, Sue LI, Belden CM. Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study. Neurol Clin Pract. 2021 Aug; 11(4):e414-e421. PMID: 34484939; PMCID: PMC8382425.
    Citations: 2     
  13. Melikyan ZA, Malek-Ahmadi M, O'Connor K, Atri A, Kawas CH, Corrada MM. Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-old. Aging Clin Exp Res. 2021 Dec; 33(12):3303-3311. PMID: 34050916; PMCID: PMC8668848.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  14. Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S. Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther. 2021 05 10; 13(1):98. PMID: 33971962; PMCID: PMC8111757.
    Citations: 41     Fields:    Translation:Humans
  15. Liss JL, Seleri Assunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J Intern Med. 2021 08; 290(2):310-334. PMID: 33458891.
    Citations: 7     Fields:    Translation:Humans
  16. Serrano GE, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Papa J, Russell A, Suszczewicz KE, Borja CI, Belden C, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Readhead B, Huentelman MJ, Peters JL, Alevritis E, Bimi C, Mizgerd JP, Reiman EM, Montine TJ, Desforges M, Zehnder JL, Sahoo MK, Zhang H, Solis D, Pinsky BA, Deture M, Dickson DW, Beach TG. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv. 2021 Feb 18. PMID: 33619496.
    Citations:    
  17. Beach TG, Russell A, Sue LI, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Hidalgo T, Chiarolanza G, Mariner M, Scroggins A, Pullen J, Souders L, Sivananthan K, Carter N, Saxon-LaBelle M, Hoffman B, Garcia A, Callan M, Fornwalt BE, Carew J, Filon J, Cutler B, Papa J, Curry JR, Oliver J, Shprecher D, Atri A, Belden C, Shill HA, Driver-Dunckley E, Mehta SH, Adler CH, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Fietz M, Lue LF, Walker DG, Mizgerd JP, Serrano GE. Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease. medRxiv. 2021 Jan 08. PMID: 33442709.
    Citations:    
  18. Dickerson B, Atri A. Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias. Pract Neurol (Fort Wash Pa). 2020 Nov-Dec; 19(9):34-45. PMID: 34456638; PMCID: PMC8387980.
    Citations:    
  19. Brooker H, Williams G, Hampshire A, Corbett A, Aarsland D, Cummings J, Molinuevo JL, Atri A, Ismail Z, Creese B, Fladby T, Thim-Hansen C, Wesnes K, Ballard C. FLAME: A computerized neuropsychological composite for trials in early dementia. Alzheimers Dement (Amst). 2020; 12(1):e12098. PMID: 33088895; PMCID: PMC7560493.
    Citations: 1     
  20. Atri A, Goldfarb D, Sheard S, Shaughnessy L. Current and Emerging Solutions to Challenges in the Management of Alzheimer's Disease. J Clin Psychiatry. 2019 12 03; 80(6). PMID: 31846243.
    Citations: 1     Fields:    Translation:Humans
  21. Atri A, Sheard S, Goldfarb D. A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease. J Clin Psychiatry. 2019 09 24; 80(5). PMID: 31556977.
    Citations: 1     Fields:    Translation:Humans
  22. Shaughnessy L, Sheard S, Goldfarb D, Atri A. Cognitive Assessment of Alzheimer's Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation. J Clin Psychiatry. 2019 06 25; 80(4). PMID: 31237995.
    Citations: 2     Fields:    Translation:Humans
  23. Ballard C, Atri A, Boneva N, Cummings JL, Frölich L, Molinuevo JL, Tariot PN, Raket LL. Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease. Alzheimers Dement (N Y). 2019; 5:164-174. PMID: 31193334; PMCID: PMC6527908.
    Citations: 7     
  24. Atri A. Current and Future Treatments in Alzheimer's Disease. Semin Neurol. 2019 04; 39(2):227-240. PMID: 30925615.
    Citations: 42     Fields:    Translation:Humans
  25. Goldfarb D, Sheard S, Shaughnessy L, Atri A. Disclosure of Alzheimer's Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication. J Clin Psychiatry. 2019 03 19; 80(2). PMID: 30900850.
    Citations: 2     Fields:    Translation:Humans
  26. Atri A. The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. Med Clin North Am. 2019 Mar; 103(2):263-293. PMID: 30704681.
    Citations: 88     Fields:    Translation:Humans
  27. El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, Karran M, Molinuevo JL, Norton M, Atri A. Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders. J Alzheimers Dis. 2019; 70(2):323-341. PMID: 31256142.
    Citations: 46     Fields:    Translation:Humans
  28. Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Geist MA, Raket LL, Cummings JL. Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease. J Alzheimers Dis. 2019; 67(1):303-313. PMID: 30636738.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  29. Cummings JL, Atri A, Ballard C, Boneva N, Frölich L, Molinuevo JL, Raket LL, Tariot PN. Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program. Alzheimers Res Ther. 2018 11 24; 10(1):116. PMID: 30474567.
    Citations: 8     Fields:    Translation:Humans
  30. Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. JAMA. 2018 01 09; 319(2):130-142. PMID: 29318278; PMCID: PMC5833662.
    Citations: 42     Fields:    Translation:Humans
  31. Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, Giordani B, Kramer J, Loewenstein D, Marson D, Mungas D, Salmon D, Welsh-Bohmer K, Zhou XH, Shirk SD, Atri A, Kukull WA, Phelps C, Morris JC. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord. 2018 Jan-Mar; 32(1):10-17. PMID: 29240561; PMCID: PMC5821520.
    Citations: 131     Fields:    Translation:Humans
  32. Shirk SD, McLaren DG, Bloomfield JS, Powers A, Duffy A, Mitchell MB, Ezzati A, Ally BA, Atri A. Inter-Rater Reliability of Preprocessing EEG Data: Impact of Subjective Artifact Removal on Associative Memory Task ERP Results. Front Neurosci. 2017; 11:322. PMID: 28670264; PMCID: PMC5472725.
    Citations:    
  33. Herman L, Atri A, Salloway S. Alzheimer's Disease in Primary Care: The Significance of Early Detection, Diagnosis, and Intervention. Am J Med. 2017 06; 130(6):756. PMID: 28449849.
    Citations: 5     Fields:    Translation:Humans
  34. Dickerson BC, McGinnis SM, Xia C, Price BH, Atri A, Murray ME, Mendez MF, Wolk DA. Approach to atypical Alzheimer's disease and case studies of the major subtypes. CNS Spectr. 2017 12; 22(6):439-449. PMID: 28196556.
    Citations: 23     Fields:    Translation:Humans
  35. Peterson K, Hahn H, Lee AJ, Madison CA, Atri A. In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers' education needs, barriers, and preferences. BMC Geriatr. 2016 Sep 23; 16(1):164. PMID: 27662829.
    Citations: 31     Fields:    
  36. Atri A, Gerson LB. Continued Questions About Whether Avoidance of Proton Pump Inhibitors Can Reduce Risk of Dementia. Gastroenterology. 2016 Sep; 151(3):555-8. PMID: 27479443.
    Citations:    Fields:    
  37. Engheta A, Hadadi Abianeh S, Atri A, Sanatkarfar M. Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial. Daru. 2016 Jul 28; 24(1):20. PMID: 27465859.
    Citations: 1     Fields:    Translation:Humans
  38. Mitchell MB, Shirk SD, McLaren DG, Dodd JS, Ezzati A, Ally BA, Atri A. Recognition of faces and names: multimodal physiological correlates of memory and executive function. Brain Imaging Behav. 2016 06; 10(2):408-23. PMID: 26116280.
    Citations: 1     Fields:    Translation:Humans
  39. Atri A. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice. Handb Clin Neurol. 2016; 136:971-84. PMID: 27430453.
    Citations: 8     Fields:    Translation:Humans
  40. Atri A, Hendrix SB, Pejovic V, Hofbauer RK, Edwards J, Molinuevo JL, Graham SM. Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis. Alzheimers Res Ther. 2015; 7(1):28. PMID: 25991927.
    Citations: 23     Fields:    
  41. McLaren DG, Sperling RA, Atri A. Flexible modulation of network connectivity related to cognition in Alzheimer's disease. Neuroimage. 2014 Oct 15; 100:544-57. PMID: 24852459.
    Citations: 10     Fields:    Translation:Humans
  42. Atri A, Molinuevo JL, Lemming O, Wirth Y, Pulte I, Wilkinson D. Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy. Alzheimers Res Ther. 2013; 5(1):6. PMID: 23336974.
    Citations: 38     Fields:    
  43. Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement. 2013 May; 9(3):338-45. PMID: 23102979.
    Citations: 27     Fields:    Translation:Humans
  44. Mitchell MB, Shaughnessy LW, Shirk SD, Yang FM, Atri A. Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysis. J Int Neuropsychol Soc. 2012 Nov; 18(6):1071-80. PMID: 23039909.
    Citations: 14     Fields:    Translation:Humans
  45. Lindwall M, Cimino CR, Gibbons LE, Mitchell MB, Benitez A, Brown CL, Kennison RF, Shirk SD, Atri A, Robitaille A, Macdonald SW, Zelinski EM, Willis SL, Schaie KW, Johansson B, Praetorius M, Dixon RA, Mungas DM, Hofer SM, Piccinin AM. Dynamic associations of change in physical activity and change in cognitive function: coordinated analyses of four longitudinal studies. J Aging Res. 2012; 2012:493598. PMID: 23029615.
    Citations: 16     
  46. Mitchell MB, Cimino CR, Benitez A, Brown CL, Gibbons LE, Kennison RF, Shirk SD, Atri A, Robitaille A, Macdonald SW, Lindwall M, Zelinski EM, Willis SL, Schaie KW, Johansson B, Dixon RA, Mungas DM, Hofer SM, Piccinin AM. Cognitively Stimulating Activities: Effects on Cognition across Four Studies with up to 21 Years of Longitudinal Data. J Aging Res. 2012; 2012:461592. PMID: 23024862.
    Citations: 36     
  47. Brown CL, Gibbons LE, Kennison RF, Robitaille A, Lindwall M, Mitchell MB, Shirk SD, Atri A, Cimino CR, Benitez A, Macdonald SW, Zelinski EM, Willis SL, Schaie KW, Johansson B, Dixon RA, Mungas DM, Hofer SM, Piccinin AM. Social activity and cognitive functioning over time: a coordinated analysis of four longitudinal studies. J Aging Res. 2012; 2012:287438. PMID: 22991665.
    Citations: 22     
  48. McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri A. Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease. Neurodegener Dis. 2012; 9(4):176-86. PMID: 22456451.
    Citations: 20     Fields:    Translation:Humans
  49. Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012; 10(1-4):170-4. PMID: 22327239.
    Citations: 13     Fields:    Translation:Humans
  50. Shirk SD, Mitchell MB, Shaughnessy LW, Sherman JC, Locascio JJ, Weintraub S, Atri A. A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res Ther. 2011 Nov 11; 3(6):32. PMID: 22078663.
    Citations: 96     Fields:    
  51. Atri A. Effective pharmacological management of Alzheimer's disease. Am J Manag Care. 2011 Nov; 17 Suppl 13:S346-55. PMID: 22214392.
    Citations: 21     Fields:    Translation:Humans
  52. Locascio JJ, Atri A. An overview of longitudinal data analysis methods for neurological research. Dement Geriatr Cogn Dis Extra. 2011 Jan; 1(1):330-57. PMID: 22203825.
    Citations: 47     
  53. Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA. Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials. Arch Neurol. 2011 May; 68(5):599-606. PMID: 21555634; PMCID: PMC3291175.
    Citations: 20     Fields:    Translation:Humans
  54. Rosenbloom MH, Atri A. The evaluation of rapidly progressive dementia. Neurologist. 2011 Mar; 17(2):67-74. PMID: 21364356.
    Citations: 22     Fields:    Translation:Humans
  55. Putcha D, O'Keefe K, LaViolette P, O'Brien J, Greve D, Rentz DM, Locascio J, Atri A, Sperling R. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Hum Brain Mapp. 2011 Dec; 32(12):2027-44. PMID: 21259385.
    Citations: 17     Fields:    Translation:Humans
  56. Atri, A, Chang M, Strichartz G. Cholinergic Pharmacology. Principles of Pharmacology: The Pathophysiological Basis for Drug Therapy. Golan et al. Editors. 2011.
  57. Slachevsky A, Muñoz-Neira C, Nuñez-Huasaf J, Stern TA, Blesius CR, Atri A. Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia. Prim Care Companion CNS Disord. 2011; 13(3). PMID: 21977365.
    Citations: 2     Fields:    
  58. A. ATRI, J.S. DODD, F.M. WANG, J. J. LOCASCIO. Presence of Extrapyramidal Motor Signs Predict Worse Cognitive and Functional Trajectory of Decline in Mild-to-Moderate Alzheimer's . Alzheimer's Assoc. ICAD (Int. Conf. on Alzheimers & Assoc. Disorders). 2010; Poster Presentation P2-125.
  59. A. ATRI, J. S. DODD, A. SREENIVASAN, P. VANNINI, J. L. O’BRIEN, P. LAVIOLETTE1, J. J. LOCASCIO1, R. A. SPERLING. A Candidate fMRI Measure Combining Hippocampal and Default Mode Network Activity to Predict Future Memory Performance in Alzheimer’s Disease . Alzheimer's Assoc. ICAD (Int. Conf. on Alzheimers & Assoc. Disorders). 2010; Oral Presentation 02-04-06.
  60. Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord. 2010 Jul-Sep; 24(3):220-6. PMID: 20473136.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  61. Alireza Atri, Sumer Verma, Sang Yun Kim. Dementia. International Textbook of Geriatric Medicine. Juergen Bludau Editor. 2010; (in press).
  62. J. S. DODD, E. T. CREHAN, A. SREENIVASAN, P. VANNINI, J. L. O’BRIEN, P. LAVIOLETTE1, J. J. LOCASCIO1, R. A. SPERLING, A. ATRI. Candidate prognostic models using fMRI measures to predict future memory performance in Alzheimer’s disease . Society for Neuroscience Abstracts. 2009; Program#/Poster#: 140.18/E20 .
  63. A. SREENIVASAN, E. T. CREHAN, J. S. DODD, E. DIAMOND, J. L. O'BRIEN, P. LAVIOLETTE, D. M. RENTZ, R. A. SPERLING, A. ATRI. Clinico-functional-anatomic relationships in Alzheimer’s disease: fMRI tracks clinical trial memory measures. Society for Neuroscience Abstracts. 2009; Program#/Poster#: 140.17/E19 .
  64. Michael R. Flaherty, B.S., Joseph J. Locascio, Ph.D., and Alireza Atri, M.D., Ph.D. Vitamin E slows functional decline and anti-inflammatories slow cognitive decline in Alzheimer’s Disease . American Geriatrics Society Annual Meeting. 2009; A117.
  65. Atri A, O’Brien J, Rastegar S, DeLuca A, O’Keefe K, LaViolette P, Diamond EL, Salisbury S, Pihlajamaki MM, Locascio JJ, Rentz D, and RA Sperling . Feasibility and Test-retest Reliability of fMRI in an Alzheimer’s Disease Clinical Trial . International Conference on Alzheimer's Disease and Associated Disorders Abstracts; Chicago, IL. 2008; 1561.
  66. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blakcer D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Moris JC, Fischl B, Buckner RL. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Inidividuals. Cerebral Cortex. 2008; epub ahead of print.
  67. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009 Mar; 19(3):497-510. PMID: 18632739.
    Citations: 442     Fields:    Translation:Humans
  68. Atri A, Shaughnessy LW, Locascio JJ, Growdon JH. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):209-21. PMID: 18580597.
    Citations: 83     Fields:    Translation:HumansCTClinical Trials
  69. Reddy, KS, Kasyer, AS, and Atri, A. . Encephalopathy: Approach to Diagnosis and Care. Hospital Physician Neurology Board Review Manual. 2008; 12(1):1-15.
  70. Dickerson BC, Bakkour A, Salat D, Rosas H, Sperling RA, Atri A, Wright CI, Grodstein F,Blacker D, Growdon JH, Hyman BT, Morris J, Buckner R. . The Cortical Signature ofAlzheimer’s Disease (AD): Reliability and Clinical Validity of This MRI-Based Quantitative Biomarker. American Academy of Neurology Annual Conference Abstracts; Chicago, IL. 2008; P08.054.
  71. Diamond EL, Miller S, Dickerson BC, Atri A, DePeau K, Fenstermacher E, Pihlajamäki M, Celone K, Salisbury S, Gregas M, Rentz D, Sperling RA. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease. Neurology. 2007 Sep 25; 69(13):1331-41. PMID: 17893294.
    Citations: 13     Fields:    Translation:Humans
  72. Atri A, Diamond E, DePeau K, Salisbury S, Celone K, Miller S, Sardinha L, Gregas M, Pihlajamaki M, Searl M, Rentz D, Sperling RA. FMRI Correlates of Face-Name Encoding Longitudinally Track with Changes in Clinical Trial Memory Measures in Alzheimer’s Disease. American Academy of Neurology Annual Conference Abstracts; Boston, MA. 2007; P08.098.
  73. Atri, A, Chang M, Strichartz G. Cholinergic Pharmacology. Principles of Pharmacology: The Pathophysiological Basis for Drug Therapy. Golan et al. Editors. 2007.
  74. Atri, A. Apparent Diffusion Coefficient on MRI and Mild Cognitive Impairment. Journal Watch Neurology. 2007; 3(213):23-24.
  75. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci. 2006 Oct 04; 26(40):10222-31. PMID: 17021177; PMCID: PMC6674636.
    Citations: 291     Fields:    Translation:Humans
  76. Kasyer, AS, and Atri, A. . Approach to the evaluation of encephalopathy. Hospital Physician Neurology Board Review Manual. 2005; 9(4):1-16.
  77. Schon K, Atri A, Hasselmo ME, Tricarico MD, LoPresti ML, Stern CE. Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. J Neurosci. 2005 Oct 05; 25(40):9112-23. PMID: 16207870; PMCID: PMC6725748.
    Citations: 61     Fields:    Translation:HumansCTClinical Trials
  78. Atri, A. Diagnosis of Common Dementias. Neurology Self-Assessment. Hospital Physician. 2005; 41(4):25-26.
  79. Qureshi SA, Atri A . The first case of definite variant Creutzfeldt-Jakob disease in the middle-east. American Academy of Neurology Annual Conference Abstracts; Miami, FL. 2005.
  80. Atri A, Locascio JJ, Lin JM, Yap L, Dickerson BC, Grodstein F, Irizarry MC, Growdon JH, Greenberg SM. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis. 2005; 2(6):305-12. PMID: 16909013.
    Citations: 10     Fields:    Translation:Humans
  81. Alexander EK, Marqusee E, Orcutt J, Benson CB, Frates MC, Doubilet PM, Cibas ES, Atri A. Thyroid nodule shape and prediction of malignancy. Thyroid. 2004 Nov; 14(11):953-8. PMID: 15671774.
    Citations: 25     Fields:    Translation:Humans
  82. Atri A, LoPresti ML, Sherman SJ, Schendan HE, Hasselmo ME, Stern CE . Central cholinergic augmentation improves reaction time but not recognition memory in young healthy adults. NeuroRx. 2004; 1(4):509-510.
  83. Atri, A. Sleeping on your cholinesterase-inhibitor: forget about it?. Journal Watch Neurology. 2004; 6(8):60-61.
  84. Atri, A. Expert commentator and interview for >50 local, national & international print, internet, radio, and TV media programs, periodicals, stories and news articles relating to cognitive aging, diagnosis and treatments of dementia and brain injury. 2004.
  85. Atri, A, Stern, CE, and Hasselmo, ME. Invited Comment on NEWS: Could Alzheimer’s Drugs Mean “Good Night” to Good Memory?. 2004.
  86. Atri A, Sherman S, Norman KA, Kirchhoff BA, Nicolas MM, Greicius MD, Cramer SC, Breiter HC, Hasselmo ME, Stern CE. Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. Behav Neurosci. 2004 Feb; 118(1):223-36. PMID: 14979800.
    Citations: 58     Fields:    Translation:Humans
  87. Atri A, Sheen V. Cavernous sinus syndrome and headache due to bilateral carotid artery aneurysms. Arch Neurol. 2003 Sep; 60(9):1327-8. PMID: 12975304.
    Citations:    Fields:    Translation:Humans
  88. Sherman SJ, Atri A, Hasselmo ME, Stern CE, Howard MW. Scopolamine impairs human recognition memory: data and modeling. Behav Neurosci. 2003 Jun; 117(3):526-39. PMID: 12802881.
    Citations: 30     Fields:    Translation:Humans
  89. Lee FS, Chu FK, Tackley M, Wu AD, Atri A, Wessels MR. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis. 2000 Nov; 31(5):1288-91. PMID: 11073767.
    Citations: 2     Fields:    Translation:HumansCells
  90. Atri, A. Clinical Microbiology and Immunology. First Aid for the USMLE Step 1. Amin, C., Bushan, V., and Le, T., Editors. 1996; 105-131.
  91. Atri, A. Clinical Pharmacology. First Aid for the USMLE Step 1. Amin, C., Bushan, V., and Le, T., Editors. 1996; 161-193.
  92. Atri A, Amundson J, Clapham D, Sneyd J. A single-pool model for intracellular calcium oscillations and waves in the Xenopus laevis oocyte. Biophys J. 1993 Oct; 65(4):1727-39. PMID: 8274661; PMCID: PMC1225900.
    Citations: 97     Fields:    Translation:AnimalsCells
  93. Sneyd, J, Atri, A. Curvature dependence of a model for calcium wave propagation. Physica D. 1993; 65(4):365-372.
  94. Sneyd, J, Atri, A, Ferguson, MWJ, Lewis, MA, Seward, W, Murray, JD. A model for the spatial patterning of teeth primordia in the Alligator: initiation of the dental determinant. J Theo Biol. 1993; (165):633-658.
  95. Atri, A, Sneyd, J. A mathematical model for the formation of the dental determinant in the Alligator. Ursus Medicus. 1993; (2):41-46.
  96. Selected from over 50 scientific abstracts since. 1991.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Atri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (189)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.